Last 48 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 32.89 | 30.80 | 26.67 | 25.34 | 34.98 | 45.23 | 43.28 | 53.93 | 52.57 | 51.47 | 35.23 | 39.45 | 40.40 | 39.22 | 59.74 | 51.35 | 30.44 | 52.32 | 50.25 | 92.39 | 43.26 |
| — | -31.9% | -38.4% | -53.0% | -33.5% | -12.1% | +22.9% | +36.7% | +30.1% | +31.3% | -41.0% | -23.2% | +32.7% | -25.1% | +18.9% | -44.4% | -29.6% | -38.8% | -72.0% | +17.3% | -15.8% | |
| P/S Ratio | 3.23 | 3.13 | 2.48 | 2.71 | 3.36 | 3.24 | 3.71 | 4.57 | 4.13 | 4.33 | 3.73 | 3.43 | 3.43 | 3.20 | 3.82 | 3.61 | 3.49 | 2.83 | 2.65 | 3.47 | 3.22 |
| — | -3.6% | -33.0% | -40.7% | -18.7% | -25.0% | -0.7% | +33.3% | +20.3% | +35.5% | -2.3% | -5.2% | -1.7% | +12.8% | +44.2% | +4.1% | +8.2% | -26.8% | -19.8% | +1.4% | +5.6% | |
| P/B Ratio | 3.33 | 2.98 | 2.48 | 2.54 | 3.34 | 3.26 | 3.81 | 4.53 | 4.25 | 4.45 | 3.94 | 3.58 | 3.69 | 3.28 | 4.06 | 3.67 | 3.58 | 2.99 | 2.91 | 3.62 | 3.45 |
| — | -8.5% | -34.9% | -43.9% | -21.4% | -26.7% | -3.3% | +26.8% | +15.2% | +35.7% | -3.1% | -2.6% | +3.2% | +9.6% | +39.5% | +1.4% | +3.6% | -26.7% | -22.0% | +3.7% | +5.1% | |
| P/FCF | 25.48 | 24.91 | 20.36 | 43.24 | 17.18 | 24.20 | 13.51 | 84.99 | 22.72 | 39.32 | 22.08 | 46.85 | 20.36 | 23.71 | 103.74 | 611.17 | 65.95 | 41.27 | 24.77 | 385.16 | 23.94 |
| — | +2.9% | +50.7% | -49.1% | -24.4% | -38.4% | -38.8% | +81.4% | +11.6% | +65.8% | -78.7% | -92.3% | -69.1% | -42.5% | +318.8% | +58.7% | +175.5% | -30.0% | -9.6% | +1181.0% | -21.8% | |
| EV / EBITDA | 16.11 | 15.24 | 11.99 | 14.45 | 16.23 | 17.59 | 19.06 | 20.77 | 23.04 | 23.18 | 18.09 | 18.86 | 20.06 | 17.47 | 24.24 | 22.80 | 20.17 | 20.95 | 18.33 | 26.82 | 21.11 |
| — | -13.3% | -37.1% | -30.4% | -29.5% | -24.1% | +5.4% | +10.2% | +14.8% | +32.7% | -25.4% | -17.3% | -0.5% | -16.6% | +32.3% | -15.0% | -4.5% | -25.1% | -39.9% | +10.1% | +2.2% | |
| EV / EBIT | 30.66 | 21.88 | 17.86 | 18.60 | 24.99 | 29.89 | 30.62 | 38.74 | 38.17 | 34.99 | 24.67 | 27.86 | 31.90 | 30.83 | 45.69 | 41.09 | 33.38 | 45.03 | 38.43 | 67.66 | 45.19 |
| — | -26.8% | -41.7% | -52.0% | -34.5% | -14.6% | +24.1% | +39.0% | +19.7% | +13.5% | -46.0% | -32.2% | -4.4% | -31.5% | +18.9% | -39.3% | -26.1% | -37.3% | -68.4% | +2.3% | -22.5% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 48.7% | 48.2% | 51.4% | 48.4% | 49.6% | 48.5% | 48.2% | 48.4% | 48.7% | 46.4% | 47.7% | 46.9% | 41.8% | 45.1% | 47.7% | 46.5% | 45.9% | 44.8% | 45.8% | 43.9% | 46.3% |
| — | -0.7% | +6.5% | -0.0% | +1.8% | +4.7% | +1.2% | +3.2% | +16.5% | +2.8% | -0.2% | +0.9% | -8.8% | +0.8% | +4.3% | +5.9% | -0.9% | -0.8% | +3.4% | -2.3% | +7.3% | |
| Operating Margin | 12.2% | 14.1% | 14.5% | 11.5% | 13.7% | 11.1% | 12.2% | 14.3% | 10.3% | 11.0% | 13.6% | 11.1% | 10.1% | 11.1% | 9.0% | 8.9% | 10.4% | 6.5% | 7.9% | 5.5% | 7.9% |
| — | +26.9% | +18.1% | -19.6% | +33.3% | +1.5% | -9.9% | +29.0% | +1.6% | -1.6% | +51.0% | +25.2% | -2.3% | +71.6% | +14.2% | +60.3% | +31.9% | +8.9% | +148.5% | -3.0% | +26.7% | |
| Net Margin | 8.5% | 10.2% | 9.3% | 10.7% | 9.6% | 7.2% | 8.5% | 8.5% | 7.9% | 8.4% | 10.6% | 8.7% | 8.5% | 8.2% | 6.3% | 7.0% | 11.4% | 5.3% | 5.2% | 3.8% | 7.4% |
| — | +40.7% | +8.6% | +26.2% | +22.5% | -13.7% | -19.3% | -2.5% | -7.9% | +2.1% | +67.1% | +25.5% | -24.9% | +54.1% | +22.0% | +81.7% | +53.8% | +18.7% | +195.7% | -13.0% | +24.2% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 8.7% | 2.5% | 2.3% | 2.6% | 2.4% | 1.8% | 2.2% | 2.1% | 2.1% | 2.2% | 2.8% | 2.3% | 2.3% | 2.1% | 1.7% | 1.8% | 3.0% | 1.4% | 1.4% | 1.0% | 2.0% |
| — | +34.3% | +5.0% | +18.9% | +18.0% | -15.7% | -21.1% | -7.1% | -9.0% | +2.8% | +66.2% | +29.4% | -24.0% | +50.3% | +18.7% | +77.7% | +49.0% | +18.4% | +187.7% | -11.2% | +23.5% | |
| ROA | 5.0% | 1.5% | 1.4% | 1.5% | 1.4% | 1.1% | 1.3% | 1.2% | 1.2% | 1.2% | 1.5% | 1.2% | 1.3% | 1.4% | 1.1% | 1.2% | 2.0% | 0.9% | 0.9% | 0.6% | 1.3% |
| — | +37.4% | +7.8% | +22.9% | +22.7% | -11.2% | -15.2% | +1.6% | -12.8% | -15.5% | +32.3% | -1.8% | -34.0% | +51.4% | +22.5% | +92.2% | +61.8% | +28.4% | +214.3% | -2.6% | +35.8% | |
| ROIC | 7.2% | 2.1% | 2.3% | 1.7% | 2.0% | 1.6% | 1.8% | 2.1% | 1.6% | 1.8% | 2.3% | 1.8% | 1.6% | 1.7% | 1.5% | 1.4% | 1.7% | 1.0% | 1.3% | 0.9% | 1.3% |
| — | +31.1% | +23.2% | -20.9% | +26.6% | -8.3% | -18.8% | +17.6% | -1.0% | +3.6% | +53.4% | +23.7% | -4.1% | +64.4% | +13.1% | +65.5% | +34.1% | +14.6% | +157.8% | +9.2% | +41.2% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.57 | 0.47 | 0.49 | 0.51 | 0.57 | 0.54 | 0.55 | 0.57 | 0.58 | 0.62 | 0.68 | 0.70 | 0.74 | 0.29 | 0.34 | 0.24 | 0.24 | 0.27 | 0.30 | 0.32 | 0.31 |
| — | -12.2% | -11.5% | -11.8% | -1.6% | -13.3% | -18.8% | -18.7% | -22.3% | +114.3% | +100.8% | +197.3% | +203.4% | +5.8% | +11.2% | -25.0% | -22.0% | -24.1% | -20.9% | -25.3% | -33.0% | |
| Debt / EBITDA | 2.82 | 9.07 | 8.68 | 10.62 | 10.16 | 10.67 | 10.19 | 9.85 | 11.66 | 12.29 | 11.94 | 13.93 | 15.09 | 5.74 | 7.56 | 5.59 | 5.23 | 7.12 | 7.06 | 8.71 | 7.15 |
| — | -14.9% | -14.8% | +7.9% | -12.9% | -13.2% | -14.7% | -29.3% | -22.7% | +114.0% | +57.9% | +149.1% | +188.5% | -19.3% | +7.0% | -35.8% | -26.8% | -22.7% | -39.1% | -18.4% | -31.6% | |
| Current Ratio | 4.34 | 4.52 | 4.20 | 5.08 | 4.34 | 4.28 | 4.09 | 4.87 | 4.27 | 5.36 | 6.24 | 6.03 | 5.45 | 3.13 | 3.13 | 2.58 | 2.40 | 2.35 | 2.52 | 2.35 | 2.04 |
| — | +5.8% | +2.6% | +4.3% | +1.6% | -20.3% | -34.5% | -19.2% | -21.6% | +71.5% | +99.4% | +133.6% | +127.1% | +33.3% | +24.3% | +10.0% | +17.5% | +8.1% | +17.9% | +11.1% | -12.1% | |
| Quick Ratio | 2.95 | 3.05 | 2.79 | 3.46 | 2.95 | 2.86 | 2.66 | 3.26 | 2.85 | 3.82 | 4.64 | 4.38 | 3.95 | 1.50 | 1.52 | 1.24 | 1.19 | 1.19 | 1.33 | 1.21 | 1.10 |
| — | +6.6% | +4.8% | +6.2% | +3.2% | -25.1% | -42.7% | -25.6% | -27.8% | +153.9% | +205.2% | +253.2% | +231.5% | +26.5% | +14.6% | +2.4% | +8.2% | -0.6% | +9.5% | +5.5% | -12.0% | |
| Interest Coverage | 7.46 | 8.61 | 5.23 | 9.21 | 9.02 | 6.71 | 7.40 | 6.78 | 5.15 | 5.89 | 6.97 | 5.27 | 7.46 | 7.24 | 7.76 | 13.68 | 14.97 | 10.61 | 16.36 | 15.14 | 19.26 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MMSI stock.
Merit Medical Systems, Inc.'s current P/E is 32.9x. The average P/E over the last 4 quarters is 29.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Merit Medical Systems, Inc.'s current operating margin is 12.2%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Merit Medical Systems, Inc.'s business trajectory between earnings reports.